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a b s t r a c t
Proliferation and differentiation are tightly controlled during neural development. In the embryonic
neural plate, primary neurogenesis is driven by the proneural pathway. Here we report the character-
ization of Maturin, a novel, evolutionarily conserved protein that is required for normal primary
neurogenesis. Maturin is detected throughout the early nervous system, yet it is most strongly expressed
in differentiating neurons of the embryonic ﬁsh, frog and mouse nervous systems. Maturin expression
can be induced by the proneural transcription factors Neurog2, Neurod1, and Ebf3. Maturin over-
expression promotes neurogenesis, while loss-of-function inhibits the differentiation of neuronal
progenitors, resulting in neural plate expansion. Maturin knockdown blocks the ability of Neurog2,
Neurod1, and Ebf3 to drive ectopic neurogenesis. Maturin and Pak3, are both required for, and can
synergize to promote differentiation of the primary neurons in vivo. Together, our results suggest that
Maturin functions during primary neurogenesis and is required for the proneural pathway to regulate
neural differentiation.
Published by Elsevier Inc.
Introduction
Normal neural development requires a precise balance of
proliferation and differentiation (Dehay and Kennedy, 2007;
Donovan and Dyer, 2005; Salomoni and Calegari, 2010). Identify-
ing the genes and signaling systems that regulate the differentia-
tion of neuronal progenitors is essential, as premature or post-
poned neurogenesis can alter the number and types of neurons
generated during development (Agathocleous and Harris, 2009;
Donovan and Dyer, 2005; Dyer and Cepko, 2001; Guillemot, 2007;
Hindley and Philpott, 2012). In Xenopus laevis the ﬁrst progenitors
to differentiate generate the primary neurons, which have served
as a valuable model for identifying the genes and signaling sys-
tems driving vertebrate neurogenesis (Henningfeld et al., 2007).
Shortly after gastrulation, the primary neurons differentiate along
three, longitudinal, bilaterally symmetric stripes on either side of
the embryonic midline and are detected by their expression of
neural-speciﬁc, class II beta-tubulin (tubb2b) (Chitnis et al., 1995;
Hartenstein, 1989; Oschwald et al., 1991).
Primary neurogenesis is driven by a cascade of proneural basic
helix–loop–helix (bHLH) transcription factors that regulate the
activity of downstream targets required for cell fate determination,
cell cycle exit and the eventual differentiation of neuronal pro-
genitors. Neurogenin 2 (neurog2; also known as X-ngnr-1), is the
ﬁrst proneural gene of the cascade and induces the expression of
the bHLH transcription factors neuronal differentiation 1 (neurod1,
also known as XNeuroD) and early B-cell factor 3 (ebf3, also known
as Xcoe3) (Lee et al., 1995; Ma et al., 1996; Pozzoli et al., 2001).
Neurog2, neurod1 and ebf3 are all expressed in the primary
neurons, and when misexpressed, can induce ectopic neurons
and drive their differentiation in vivo and in vitro (Lee et al., 1995;
Ma et al., 1996; Pozzoli et al., 2001).
The p21-activated kinase 3 (Pak3) functions downstream of the
proneural transcription factors and is required for cell cycle exit
and differentiation of the primary neurons (Souopgui et al., 2002).
Neurog2, neurod1 and ebf3 can all induce ectopic expression of
pak3. Pak3 expression is detected in the primary neurons as they
differentiate in the neural plate. Similarly, the cells of other neural
tissues also express pak3 during differentiation. Pak3 function is
required for primary neurons to exit the cell cycle and differenti-
ate, since morpholino oligonucleotides that block pak3 translation
inhibit neural differentiation and increase cell proliferation, result-
ing in neural plate expansion. Pak3 can be made constitutively
active by artiﬁcial myristoylation, which targets the protein to cell
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membranes. Misexpression of myrPak3 results in cell cycle arrest
and premature neuronal differentiation. Interestingly, non-
myristoylated Pak3 was found to be functionally inactive, as it
neither altered primary neurogenesis (tubb2b expression), nor
embryonic development when misexpressed (Souopgui et al.,
2002).
Here we report the identiﬁcation of Maturin, an acidic, evolu-
tionarily conserved protein that is required for normal primary
neurogenesis. Maturin has no identiﬁable functional or structural
domains, yet its primary amino acid sequence has been highly
conserved in vertebrates. X. laevis maturin is detected throughout
the early nervous system, but is most highly expressed in differ-
entiating neurons. A similar expression pattern is observed in both
zebraﬁsh and mouse embryos. Blocking Maturin function inhibits
differentiation of the primary neurons, increases the number of
proliferating neural progenitors, and results in neural plate enlar-
gement. Conversely, Maturin overexpression promotes neural
differentiation within the neural plate. The proneural pathway
transcription factor(s) Neurog2, Neurod1 and Ebf3 can all induce
maturin transcription and Maturin knockdown blocks neural
differentiation initiated by Neurog2, Neurod1 and Ebf3. Maturin
gain- and loss-of-function phenotypes mimic those of Pak3, and
Maturin and Pak3 functions are both required for differentiation of
the primary neurons. Maturin and the constitutively active myr-
Pak3 can synergistically drive primary neurogenesis. Surprisingly,
Maturin can also synergize with non-myristoylated Pak3. Our
results suggest that Maturin and Pak3 are both required, and
function synergistically in the neural plate to regulate normal
primary neurogenesis.
Materials and methods
Animals
Xenopus embryos were obtained by in vitro fertilization follow-
ing standard protocols and developmental stages were determined
according to Nieuwkoop and Faber (1994). Wild-type AB and Tg
(elav3l:GFP) zebraﬁsh (Danio rerio) were obtained from the Zebra-
ﬁsh International Resource Center (ZIRC). Zebraﬁsh embryos were
staged as described (Kimmel et al., 1995). Swiss Webster E14.5
timed-pregnant females were purchased from Charles River
Laboratories International (Wilmington, MA). The Committee for
the Humane Use of Animals at SUNY Upstate Medical University
approved all procedures.
Xenopus Maturin and ortholog analysis
The X. laevis (IMAGE: 5570100; pCMVSport6.Maturin) and
mouse (IMAGE: 4535651; pCMVSport6.mouseMaturin) full-
length cDNA clones was purchased from Open Biosystems (Ther-
moScientiﬁc, Huntsville, AL). Zebraﬁsh Maturin (Accession: NM_
001144806) was PCR ampliﬁed from 48 hpf whole larvae cDNA
using primers DrMaturinfor and DrMaturinrev (Supplementary
Table S1), TA cloned, and sequence veriﬁed. Putative Maturin
orthologs were identiﬁed using BLASTP and/or BLASTN searches
of GenBank and ENSEMBL databases. Protein sequences were
aligned using the ClustalW algorithm and MegAlign ver. 10.1.2
(DNASTAR Inc., Madison, WI). Maturin is required for the differ-
entiation (maturation) of neural progenitors, hence the name (ﬁrst
suggested by Andrea Viczian). The Human Gene Nomenclature
Committee has approved the ofﬁcial gene name as: “maturin,
neural progenitor differentiation regulator homolog (Xenopus)”,
and the gene symbol as MTURN.
Plasmid construction
pCS2R.MattargetYFP was generated by ampliﬁcation of YFP
(primers YFPfor and YFPrev) and Mattarget (primers Mattargetfor
and Mattargetrev) (Supplementary Table S1). PCR products were TA
cloned, then excised and ligated in frame into pCS2R. pCS2R.Pak3
was obtained by excising Pak3 from pBK-CMV.Pak3 and ligating into
pCS2R. Construction of pCS2.Ngnr1, pCS2þMT.XNeuroD, pCS2.Xeb
f3, and pCS2.myrPak3 were previously described (Lee et al., 1995;
Ma et al., 1996; Pozzoli et al., 2001; Souopgui et al., 2002). All plas-
mids and sequences are available upon request.
Reverse transcription PCR analysis
For analysis of maturin expression at different stages ﬁve eggs
or whole embryos at the indicated stages were homogenized using
Qiashredder (Qiagen, Valencia, CA), total RNA was extracted
(RNeasy Mini Kit; Qiagen), and cDNA was synthesized using
500 ng of total RNA (Quantitect Reverse Transcription Kit; Qiagen)
per manufacturers' instructions. RT-PCR was performed using
equal amounts of template cDNA. The primer pairs used were
Maturinfor and Maturinrev, Pax6for and Pax6rev, and H4for with
H4rev (Supplementary Table S1) (Zuber et al., 2003). For zebraﬁsh
maturin cloning, 30 embryos at 48 hpf were homogenized in
TRIzol reagent (Life Technologies, Invitrogen, Grand Island, NY)
to extract total RNA. Zebraﬁsh cDNA was synthesized using 500 ng
total RNA (M-MLV Reverse Transcriptase; Promega, Madison, WI)
per manufacturer's instructions.
Animal cap assay
Total RNA was isolated from animal caps (10 per condition) or
two embryos per stage, reverse transcribed and RTPCR performed
as previously described (Viczian et al., 2009; Zuber et al., 2003).
The primers used were tubb2for, tubb2brev, ncam1for, ncam1rev,
actc1for, actc1rev (Supplementary Table S1).
Antisense morpholino oligonucleotides, RNA synthesis and
microinjection
Embryos were injected into one ventral blastomere at the 8-cell
stage with 30 ng of CoMO or MatMO2 with 200 pg nlsβ-Gal cRNA.
Noggin (20 pg) was used as a positive control. Sox2 expression was
detected by in situ hybridization as described below. Capped RNAs
were synthesized in vitro from NotI linearized plasmids using the
SP6 mMessage Machine kit (Ambion, Austin, TX). CoMO, Pak3MO
and MatMO1/2 morpholino oligonucleotides were obtained
from GeneTools (Philomath, OR; Supplementary Table S1). cRNAs
and morpholinos were injected into one blastomere at the 2-, 4- or
8-cell stages. Embryos were devitellinized at stage 10, cultured to
stage 15, and the relative size of the neural plate was determined
using an optical micrometer.
Probes and whole mount in situ hybridization
Digoxigenin (DIG) or ﬂuorescein (FL)-labeled antisense ribop-
robes were transcribed in vitro from pCMVSport6.Maturin (EcoRI,
T7), pCMVSport6.mouseMaturin (BamHI, T7), pGEMTEZ.zebraﬁsh-
Maturin (NdeI, T7), pBSKSþ .tubb2b (BamHI, T3), pBSSKþ .Sox2
(XbaI, T7), and pGEM-T Easy.Rax (NcoI, SP6) using RNA Polymerase
Plus (Ambion) as previously described (Good et al., 1989; Mizuseki
et al., 1998; Zuber et al., 2003). Fast Red (Roche) was used to
visualize probes when section in situs were co-labeled with DAPI.
β-Gal staining and wholemount in situ hybridization was
performed as described previously (Viczian et al., 2006; Zuber
et al., 2003). In situ hybridization of tissue sections was performed
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as previously described (Chalmers et al., 2003; Regad et al., 2007;
Viczian et al., 2006), except that stage 15 and 32 embryos were
ﬁxed in Dent's ﬁxative and embedded in 15% ﬁsh gelatin/15% for
sectioning.
Immunohistochemistry and BrdU labeling
For immunohistochemistry sections were stained as previously
described (Viczian et al., 2003), with the exception that blocking
was done for 1 h. Phosphorylated Histone H3 wholemount immu-
nostaining was carried out as previously described (Saka and
Smith, 2001; Sive et al., 2000). For bromodeoxyuridine (BrdU)
labeling, stage 32 embryos were incubated in 1 mM BrdU (Sigma,
St. Louis, MO) in 0.1X Modiﬁed Marc's Ringer (MMR) solution for
3 h at 18 1C. Stage 42 embryos were incubated in BrdU for 3 h at
RT. Primary antibodies were anti-GFP polyclonal (1:500; Life
Technologies, Madison, WI), anti-BrdU monoclonal (1:20, clone
G3G4; DSHB, Iowa City, IA), anti-PCNA (1:250, Sigma, St. Louis,
MO), anti-phophorylated Histone H3 (1:1000, Millipore, Billerica,
MA) and anti-acTUBB3B (TuJ1) (1:1000, Covance, Princeton, NJ).
Secondary antibodies were goat anti-rabbit Alexa Fluor 488, goat
anti-mouse Alexa Fluor 555, goat anti-mouse IgG2a Alexa Fluor
555, goat anti-mouse IgG2a Alexa Fluor 488 (all at 1:500;
Molecular Probes, Invitrogen, Eugene, OR), and goat anti-rabbit
IgG-HRP (1:1000, Millipore, Billerica, MA).
TUNEL staining
Wholemount TUNEL staining was performed as described
(Hensey and Gautier, 1998). For imaging, embryos were dehy-
drated in 100% methanol and cleared in BBBA (2 parts Benzyl
Benzoate: 1 part Benzyl alcohol). TUNEL counts were performed
within an area of 0.138 mm2 on both sides of the midline of each
embryo using Image J (NIH) plugins for cell counting and ROI
managing.
Western blotting
Using standard protocols, 30 mg of total protein was loaded per
lane, separated by SDS-PAGE and blotted onto a PVDF membrane
(BioRad). Antibodies used were polyclonal anti-GFP (1:1000;
Molecular Probes), polyclonal anti-β-actin (1:1000; Cell Signaling,
Danvers, MA) and goat anti-rabbit HRP conjugate (1:1000; Milli-
pore, Billerica, MA).
Neural plate/eye ﬁeld expansion, cell density and neural plate cell
number
Sox2 and rax expression domains were determined by measur-
ing the distance from the midline to lateral edge of expression and
the average size 7s.e.m determined. Cell density was determined
by counting the number of DAPI positive nuclei within a
100 μm200 μm area in ﬁve consecutive sections per embryo
and averaging. Total neural plate cell number was calculated by
counting all nuclei within the sox2 expression domain on 3 con-
secutive sections per embryo and averaging. All graphs and
statistical analysis was performed using Graph Pad Prism version
5.0c (Graph Pad Software, La Jolla, CA). Two tailed Student's t-tests
were used and Pr0.05 was considered signiﬁcant.
Image acquisition and processing
Whole embryo images were taken using a Leica MZ16A
ﬂuorescence stereomicroscope with a MicroPublisher 3.3 RTV
digital camera (Q-Imaging, Surrey, BC, Canada) and Q-Capture
software version 3.1.2 (Q-Imaging, Surrey, BC, Canada). Section
images were obtained with a DM6000 B upright microscope with
motorized Z-focusing (Leica Microsystems, Bannockburn, IL) ﬁtted
with a Retiga-SRV camera (Q-Imaging) and Volocity Software
version 6.2.1 (PerkinElmer). All images were prepared for publica-
tion using Photoshop and Illustrator CS6 version 13.0.4 (Adobe
Systems Inc., San Jose, CA).
Results
Maturin is a novel, evolutionarily conserved vertebrate protein
Maturin was identiﬁed in a screen designed to detect genes
required for eye ﬁeld speciﬁcation ((Viczian et al., 2009) and M.E.
Zuber, unpublished). The X. laevis maturin cDNA codes for a
predicted protein of 131 amino acids (a.a.) with a molecular
weight of 15 kDa (Fig. 1A). A search of protein domain databases
(including Prosite, InterProScan, NCBI Conserved Domain Database
and Motif-Scan) failed to identify any known functional or struc-
tural motifs (Marchler-Bauer et al., 2011; Pagni et al., 2007;
Quevillon et al., 2005; Sigrist et al., 2010). Putative signal peptide
cleavage sites were not detected suggesting Maturin is not a
secreted protein (Petersen et al., 2011). Maturin is an acidic protein
with a predicted net charge of 21.5 at pH 7 (pI¼3.9). Thirty of
the 131 Maturin residues are either aspartic (D) or glutamic
(E) acid, nearly half of which are located in a 22 residue acidic
domain near the carboxy-terminus (Fig. 1A; asterisks).
Whole genome scans indicated the presence of a single maturin
gene in diploid vertebrate organisms. No signiﬁcant homology
with any other gene was detected (not shown). Despite the lack of
any identiﬁable functional domain, Maturin has been highly
conserved among vertebrate species (Fig. 1A). The X. laevisMaturin
protein is 92.4% and 90.8% identical to the human (synonym
C7ORF41) and mouse (synonym 2410066E13RIK) Maturin pro-
teins, respectively (Fig. 1B). Less conservation is observed with the
predicted chicken and zebraﬁsh orthologs (Fig. 1B). Of the 30
highly acidic amino acids (aspartic and glutamic acid) in X. laevis
Maturin, 19 are invariant (Fig. 1A). Of the remaining 11 variant
positions, all but four (two in chicken, two in zebraﬁsh) are
conservative (D-E or E-D) substitutions (Fig. 1A, caret). We also
identiﬁed a novel 29-residue region (a.a. 54–82 of X. laevis) with
perfect conservation (Fig. 1A). Due to its high level of conservation
this region was named the Maturin Motif (Fig. 1A; red over-line).
Maturin is expressed maternally and is enriched in neural tissues
By RT-PCR maturin was detected in the egg, indicating it is
expressed maternally (Fig. 1C). In contrast to pax6 transcripts,
which were only detected after the late blastula stage (stage 9),
maturin was detected through the eye vesicle stage (stage 20).
Maturin transcript was ﬁrst detected by whole mount in situ
hybridization in blastula, with the most intense staining located in
the animal half of the embryo (Fig. 1D and E). Expression extends
into the marginal zone, but was not observed in other areas of the
vegetal half of the embryo, nor in the outer epithelial cell layer of
the blastocoel roof (Fig. 1E). At the small yolk plug stage (stage
12.5), expression was faint in central and posterior regions of the
neural plate, yet robust in the anterior neural plate, including the
eye ﬁeld (Fig. 1F; ef). By the neurula stage (stage 15), expression
became more intense in the posterior neural plate (Fig. 1G).
Expression is also ﬁrst detected in presumptive neural crest at
these stages. At later developmental stages, transcripts appeared
restricted to the developing nervous system (Fig. 1H-K). Expression
was detected in the developing brain, spinal cord and optic vesicles
at early and late tailbud stages (stages 24 to 31; Fig. 1J and K).
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Fig. 1. Maturin predicted protein sequence, conservation and expression during X. laevis embryonic development. (A) Maturin protein sequence alignment. Predicted amino
acid sequence of X. laevisMaturin aligned with putative orthologs from other vertebrates. Periods indicate amino acid identity, while gaps (dashes) were inserted to optimize
the alignment. The 29-residue Maturin Motif is indicated by a red over-line. Aspartic (D) and glutamic (E) amino acids in the acidic domain are labeled with asterisks. The
four positions at which non-conservative changes of highly acidic amino acids have taken place are indicated with a caret (\widehat). (B) Amino acid identity among
vertebrate Maturins. Percent identity shared with X. laevis Maturin is shown. Genbank accession numbers are: X. laevis BC045253, Homo sapiens NM_152793 (C7orf41), Mus
musculus BC042507 (2410066E13Rik), Gallus gallus XM_003640720.1, D. rerio NM_001144806. (C) Detection of maturin and pax6 transcripts using RT-PCR. Gene speciﬁc
primers were used to detect maturin and pax6 transcripts in total RNA isolated from eggs (E) and whole embryos of the indicated developmental stage. Histone h4 was used
as a loading control. (D–K) Maturin expression in developing embryos. Whole mount in situ hybridization was used to detect X. laevis maturin expression. Developmental
stage is indicated above each panel. (E) Stage 9 embryo cut open with a razor following whole mount in situ hybridization. An, animal; Veg, vegetal; b, blastocoel; A, anterior;
P, posterior; np, neural plate; ef, eye ﬁeld; nc, neural crest; D, dorsal; V, ventral; sc, spinal cord; ov, optic vesicle; e, eye. Scale bars, 400 μm.
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Thus,maturin codes for a novel evolutionarily conserved vertebrate
gene, which is expressed maternally, but is enriched in neural
tissues.
Maturin is expressed in differentiating neurons of the vertebrate
nervous system
Whole mount in situ hybridization indicated that frog maturin
transcripts were expressed in developing neural tissues (Fig. 1). To
conﬁrm this observation and determine if maturin is similarly
expressed in other vertebrates, in situ hybridization was used to
detectmaturin expression in brain, spinal cord and retinal sections.
Markers that label mitotic and differentiated regions were also
used to compare the maturin expression patterns of actively
proliferating and post-mitotic regions of the nervous system.
Regions of neural differentiation can be identiﬁed by the very
early expression of neural-speciﬁc type II β tubulin (tubb2b)
(Chitnis et al., 1995; Oschwald et al., 1991). Similar to tubb2b,
maturin transcripts were detected in the dividing (BrdU-positive)
cells of the frog ventricular zone, but were more intensely
expressed in post-mitotic (BrdU-negative) neurons of the stage
32 spinal cord and brain (Fig. 2A–B″). Similar results were
observed in the retina. However, maturin was expressed more
broadly than and preceded tubb2b in later differentiating regions
(Fig. 2C–C″). Retinal ganglion cells (RGCs) are the ﬁrst neurons of
the Xenopus retina to exit the cell cycle and differentiate (Holt
et al., 1988). Maturin expression was detected most intensely
throughout the presumptive RGC layer before tubb2b expression
(compare Fig. 2C to C′). Similarly, maturin expression precedes that
of tubb2b throughout the central retina, but was signiﬁcantly
reduced or undetectable in the most peripheral region, where
retinal progenitors continue to divide (Fig. 2C and C″). In stage 42
tadpoles, when central retinal differentiation is complete, maturin
expression is signiﬁcantly reduced (relative to earlier stages and
tubb2b; Fig. 2D and D′). Maturin transcripts were not detected in
the proliferating cells of the ciliary marginal zone, but were
detected adjacent to the CMZ, where maturin expression overlaps
that of tubb2b (Fig. 2D and D′, inset). Maturin transcripts were not
detected in the lens at any stage tested (Fig. 2C and D and not
shown).
Zebraﬁsh maturin expression in the developing retina, brain
and spinal cord was similar to that of GFP driven from the elav3l
promoter/enhancer (elav3l:GFP), which marks early born, differ-
entiating neurons (Park et al., 2000). Similar to frog, zebraﬁsh
maturin expression was absent or reduced in proliferating (PCNA-
positive) cells of the ventricular zones (Fig. 2E–F″). In the early
retina, maturin transcripts were detected in elav3l:GFP-positive
presumptive ganglion cells (Fig. 2G–G″). Maturin was not detected
in the retina before the onset of ganglion cell differentiation (not
shown). At later stages, similar to elav3l:GFP, maturin was
expressed in differentiated ganglion cells and the IPL (Fig. 2H
and H′), yet was absent from proliferating cells of the ciliary
marginal zone (Fig. 2H and H″). elav3l:GFP expression appeared to
preceded maturin expression in the ﬁsh INL (Fig. 2H and H′). As in
frog, ﬁsh maturin was not detected in the lens at any develop-
mental stage tested (Fig. 2G, H and not shown).
As in ﬁsh and frog, mouse Maturin transcripts were detected in
differentiating cells of the embryonic brain, spinal cord and retina
(Fig. 2I–K″). Mouse Maturin transcription was most intense in
differentiating (acTUBB3B-positive) cells and was undetectable or
reduced in proliferating (PCNA-positive) cells (Fig. 2I–K″).
In summary, maturin transcripts are expressed prior to and in
differentiating neurons and are reduced or absent in regions of the
developing nervous system that are actively proliferating. Further-
more, this pattern of maturin expression appears to be
evolutionarily conserved as similar patterns are observed in ﬁsh,
frog and mice.
Maturin knockdown results in neural plate expansion
Two non-overlapping antisense morpholino oligonucleotides
(MatMO1 and MatMO2) were generated to inhibit maturin trans-
lation (Figs. 3A, S1A). A reporter construct (Mat target-YFP),
generated by fusing the morpholino target sites with the open
reading frame of YFP, was used to determine if the morpholinos
could inhibit protein translation (Figs. 3B, S1B). Embryos were
injected with capped RNA (cRNA) coding for YFP or the Mat target-
YFP fusion alone, or with morpholinos. Western blot analysis was
performed on whole embryo extracts to detect expression of YFP
or fusion protein (Fig. 3C). YFP protein was detected when YFP
cRNA was injected alone, or with control or Maturin morpholinos
(Fig. 3C; lanes 2–4 and not shown). Similarly, Mat target-YFP
protein was detected when injected alone or with control mor-
pholino (Fig. 3C; lanes 5 and 6). In contrast, the Mat target-YFP
fusion protein was undetectable when coinjected with MatMO2
(Fig. 3C; lane 7). To conﬁrm target knockdown in living embryos,
ﬂuorescence was analyzed in neurula embryos that had been
injected in one blastomere at the two-cell stage with cRNA coding
for Mat target-YFP, mCherry RFP (as a tracer) and either control or
Maturin morpholinos (Figs. 3D–F″, S1C–F″). Both mCherry and YFP
ﬂuorescence were detected when injected alone (Fig. 3D–D″; 100%
of embryos mCherry and YFP positive, n¼40) or in combination
with control morpholino (Fig. 3E–E″; 100% of embryos mCherry
and YFP positive; n¼50). However, only mCherry was detected
with coinjection of Maturin morpholino (Fig. 3F–F″; 100% of
embryos mCherry positive; 0% of embryos YFP positive; n¼44).
These results demonstrate the Maturin morpholinos can inhibit
the translation of transcripts containing the maturin target
sequence in vivo.
Coincident with the loss of YFP ﬂuorescence, we also observed
an expansion of the neural plate on the Maturin morpholino-
injected side of embryos (compare Fig. 3D and E with F). Both
MatMO1 and MatMO2 expanded the neural plate (Figs. 3 and S1).
However, due to the greater frequency with which it could
generate the expanded neural plate phenotype (MatMO1; 67%,
n¼58 vs. MatMO2; 80%, n¼45), MatMO2 was used for all
subsequent experiments. To conﬁrm neural plate expansion,
in situ hybridization was used to detect changes in the expression
of sox2 (neural plate) and rax (eye ﬁeld) (Andreazzoli et al., 2003;
Mathers et al., 1997; Mizuseki et al., 1998). Unilateral injection of
the control morpholino did not alter neural plate size on the
injected side (Fig. 3G; 0%, n¼65), and the expression patterns of
sox2 and rax remained bilaterally symmetric (Fig. 3H, I, M; sox2,
487.479.1 μm uninjected side vs. 495.478.1 μm injected side,
n¼65; and rax, 38075.1 μm uninjected side vs. 377.274.8 μm
injected side, n¼58; ns P40.05). In contrast, the neural plate
(Fig. 3J) and expression domains of both sox2 and rax (Fig. 3K and
L), were enlarged with Maturin knockdown (Fig. 3M; sox2,
474.175.5 uninjected side vs. 514.675.2 μm injected side,
n¼74; and rax, 377.878.8 uninjected side vs. 423.579.0 μm
injected side, n¼63; ***Po0.0001). These results, and the obser-
vation that two, non-overlapping Maturin morpholinos generate
the same phenotype, strongly suggest that Maturin knockdown
results in neural plate expansion.
Maturin knockdown expands the neural plate by increasing cell
number
Neural plate enlargement could result from either larger cells,
or an increase in the number of cells. If due to an increase in cell
size, the number of cell nuclei per unit area (nuclear density)
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should be reduced in morpholino injected embryos (Fig. 4A).
Nuclear density was compared on both sides of the embryonic
midline in embryos unilaterally injected with Maturin morpho-
lino. For comparisons, we selected bilaterally symmetric regions of
equal size within the areas of the anterior neural plate showing
the greatest change in neural plate size (Fig. 4B). Counts of DAPI-
labeled nuclei showed that the average nuclear density on the
uninjected and Maturin morpholino-injected sides of embryos
were similar (Fig. 4C; uninjected side 3971 cells/0.02 mm2,
n¼2520 cells vs. MatMO2-injected side 3871 cells/0.02 mm2,
n¼2583 cells, P¼0.5812). This result suggests Maturin knock-
down did not alter cell size and was therefore not likely to be
responsible for neural plate expansion.
To determine if Maturin knockdown increased cell number
within the expanded neural plate region, sections of neurula
embryos were costained for sox2 by in situ hybridization to
identify the boundary of the neural plate, and with DAPI to identify
cell nuclei. Sox2 expression was clearly expanded in sections, con-
sistent with the sox2 expansion observed in whole mount embryos
(Figs. 3K and 4D). Importantly, the average number of DAPI-labeled
cells within the sox2 expressing domain was signiﬁcantly higher on
the Maturin morpholino-injected side (Fig. 4E; uninjected side
193710 cells/section, n¼5649 cells vs. MatMO2-injected side
23079 cells/section, n¼6702 cells, P¼0.0101). Together, these
results indicate that Maturin knockdown expands the neural plate
by increasing cell number and not by altering cell size.
The increase in neural plate cell number following Maturin
knockdown does not result from a reduction in cell death or a change
in cell fate
Neural plate enlargement following Maturin knockdown could
result from a reduction in cell death during embryonic develop-
ment, ultimately leading to a larger pool of neural progenitors and
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a larger neural plate. To determine if Maturin knockdown inhib-
ited cell death, embryos were stained using the Terminal deox-
ynucleotidyl transferase dUTP nick end labeling (TUNEL) method.
The number of TUNEL-positive cells on the control and mor-
pholino-injected sides of embryos were compared (Fig. 4F–H).
The control morpholino did not signiﬁcantly alter the number of
TUNEL-positive cells (Fig. 4F and H; uninjected side 070 vs.
CoMO-injected side 171; n¼15 embryos). In contrast, Maturin
knockdown dramatically increased the number of TUNEL-positive
cells (Fig. 4G and H; uninjected side 371 cells vs. MatMO2-injected
side 109719; n¼16 embryos). These results are consistent with other
reports in which an increase in apoptotic cell death was observed
following excessive proliferation in the Xenopus nervous system
(Klisch et al., 2006; Zuber et al., 1999). We conclude that neural plate
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expansion following Maturin knockdown, did not result from a
reduction in cell death.
Neural plate enlargement in response to Maturin knockdown
could result from a change in cell fate. Conversion of cells from a
non-neural to neural lineage would result in an increase in the
number of neural plate cells and a larger neural plate. To
determine if Maturin loss of function was sufﬁcient to induce
neural tissue, we injected Maturin morpholinos into both blas-
tomeres of two-cell staged embryos, collected animal poles prior
to gastrulation (stage 8.5) and cultured the explants to the
equivalent of neurula stages. In contrast to the neural inducers
noggin (nog) and neurog2, Maturin morpholinos did not induce the
expression of the neural progenitor markers neural cell adhesion
molecule 1 (ncam1) or tubb2b, suggesting Maturin knockdown is
not sufﬁcient to induce neural tissue (Fig. 4I).
Although unable to induce neural markers in isolated primitive
ectoderm, it is still possible that morpholino-mediated knockdown
of Maturin could result in neural expansion in vivo. Therefore we
injected Maturin morpholinos into ventral blastomeres at the 8-cell
stage, cultured the embryos to neurula stages and used in situ
hybridization to detect sox2 expression. Noggin was sufﬁcient to
induce ectopic neural tissue in every injected embryo, resulting
in expansion of the sox2 expression domain (Fig. 4J, 100%, n¼82).
In contrast, control and Maturin morpholinos neither expanded the
neural plate nor induced ectopic sox2 expression in ventrally
injected embryos (Fig. 4K, L; CoMO, 0%, n¼56; MatMO2, 0%, n¼40).
These results indicate that Maturin knockdown is not sufﬁcient
to induce neural markers in vitro or in vivo, and is therefore
unlikely to drive neural plate expansion by conversion of early
progenitors from a non-neural to neural lineage.
CoMO MatMO2
maturin
tu
bb
2b
pH
H
3
inj inj
tu
bb
2b
Uninjected
β -Gal
CoMO MatMO2
Fig. 5. Maturin knockdown inhibits differentiation of neural progenitors. (A–C) Whole mount in situ hybridization for tubb2b following Maturin knockdown. tubb2b
expression in CoMO injected (A), uninjected (B), or MatMO2 injected embryos (C). A similar effect on tubb2b expression was also observed with MatMO1 (Fig. S1G). (D–F)
Proliferation in morpholino-injected embryos. Proliferating cells were labeled using pHH3 whole mount immunostaining in CoMO (D) and MatMO2 injected embryos (E).
Insets in D and E show the 0.138 mm2 area on the control and injected side of each embryo in which pHH3-positive cells were counted to generate the results (F). (G-I)
Whole mount in situ hybridization for tubb2b aftermaturin overexpression. tubb2b expression in β-Gal (G) andmaturin cRNA (H) injected embryos. In all panels of this ﬁgure,
the injected side is to the right (viewer's perspective). The s.e.m. is shown. P-values obtained using Student's t-test: **P¼0.0023. Scale bars, 400 μm.
R.I. Martinez-De Luna et al. / Developmental Biology 384 (2013) 26–4034
Maturin knockdown expands the neural plate by inhibiting neuronal
differentiation
An increase in neural plate cell number could result from an
accumulation of neural progenitor cells resulting from a failure to
differentiate. To test this possibility, we used whole mount in situ
hybridization for tubb2b, to determine the effect of Maturin
knockdown on primary neurogenesis. In embryos injected uni-
laterally with control morpholino, tubb2b expression remained
bilaterally symmetric in the vast majority of embryos, with only a
small minority showing asymmetric expression (Fig. 5A; 3%, n¼
105). The frequency of asymmetry was similar to that observed in
uninjected embryos, suggesting an infrequent, yet detectable vari-
ation in tubb2b expression during normal development (Fig. 5B;
3%, n¼91). In contrast, tubb2b expression was dramatically
reduced or completely lost on the injected side of every Maturin
morpholino-injected embryo (Fig. 5C; 100%; n¼290). Similar
results were observed with MatMO1 (Fig. S1G). These results
suggest that Maturin knockdown blocks the differentiation of
the primary neurons.
Inhibition of differentiation could result from an increase in the
number of proliferating neural progenitor cells. To determine if
Maturin knockdown also increased proliferation in the neural
plate, mitotic cells were labeled using phosphohistone H3 whole-
mount immunostaining. The ratio of mitotic cells on the injected
vs. uninjected side of control and Maturin morpholino injected
embryos was compared (Fig. 5D–F). Since neural plate expansion
was most dramatic anteriorly, we selected this region of the neural
plate to score. Control morpholinos only slightly increased the
number of mitotic cells detected (injected/uninjected¼1.2347
0.047; n¼1916 pHH3þ cells on injected side versus 1684 cells on
uninjected side of 116 embryos; Fig. 5D and F). However, the ratio
of mitotic cells between the injected and uninjected side was
consistently higher in Maturin morpholino injected embryos
(injected/uninjected¼1.50570.068; n¼2249 pHH3þ cells on
the injected side versus 1759 cells on uninjected side of 148
embryos; Fig. 5E and F). From these results we conclude that
Maturin knockdown not only inhibited neuronal differentiation,
but also increased the number of proliferating cells in the
neural plate.
The above results suggest that Maturin function is required for
primary neurogenesis. If so, excessive Maturin might be expected
to promote the differentiation of the primary neurons. To test this
possibility, we overexpressed Maturin unilaterally by cRNA injec-
tion, and stained embryos for tubb2b expression. Injection of βgal
cRNA, had no effect on primary neurogenesis (Fig. 5G). In contrast,
maturin cRNA resulted in an increase in the number of tubb2b-
positive cells only on the injected side of embryos (Fig. 5H; 43%;
n¼172 embryos). The increase in tubb2b expression was restricted
to the neural plate, as ectopic tubb2b expression was not detected
in more lateral or ventral regions. We conclude, that Maturin is
sufﬁcient to induce the differentiation of primary neurons in the
context of the neural plate.
Our results indicate that Maturin function is required for the
differentiation of the primary neurons. When misexpressed,
Maturin can induce excessive neural differentiation. Conversely,
blocking Maturin function inhibits neural differentiation, increases
the number of proliferating neural progenitors and ultimately
results in an enlarged neural plate.
Maturin transcription is induced by the proneural transcription
factors Neurog2, Neurod1 and Ebf3
The above results suggest Maturin is required for normal
primary neurogenesis. Differentiation of the primary neurons is
driven by transcription factors of the proneural pathway
(Henningfeld et al., 2007). To determine if maturin transcription
could be induced by the proneural transcription factors, we
injected cRNA coding for neurog2, neurod1 or ebf3 into one
blastomere at the 2-cell stage and used whole mount in situ
hybridization to determine the effect on maturin expression. No
change in maturin expression was detected when YFP was
expressed alone (Fig. 6A and A′; 0%, n¼27). In contrast, expression
of neurog2, neurod1, or ebf3 all resulted in unilateral, ectopic trans-
cription ofmaturin (Fig. 6B D′; neurog2, 54%, n¼35; neurod1 1, 39%,
n¼36; ebf3, 86%; n¼35). These results suggested to us that
Maturin may function downstream of the proneural transcription
factors.
Maturin function is required for the activity of the proneural
transcription factors Neurog2, Neurod1 and Ebf3
When overexpressed, proneural genes induce ectopic primary
neurons as determined by expression of the neuronal marker
tubb2b (Lee et al., 1995; Ma et al., 1996; Pozzoli et al., 2001).
To determine if Maturin might function within the proneural
pathway, we coinjected cRNA coding for the proneural transcrip-
tion factors neurog2, neurod1 or ebf3, with either CoMO or
MatMO2. Misexpression of neurog2, neurod1, or ebf3 by cRNA
injection resulted in unilateral, ectopic expression of tubb2b as
previously reported (Fig. 6E, H and K; neurog2, 99%, n¼86;
neurod1, 100%, n¼67; ebf3, 100%; n¼30) (Lee et al., 1995; Ma
et al., 1996; Pozzoli et al., 2001). Coinjection of control morpholino
did not alter the ability of the proneural transcription factors to
induce ectopic tubb2b expression (Fig. 6F, I and L; neurog2þCoMO,
100%, n¼75; neurod1þCoMO, 100%, n¼61; ebf3þCoMO, 97%;
n¼32). In contrast, Maturin knockdown reduced or completely
blocked ectopic tubb2b expression in 92%, 89% and 100% of
embryos injected with neurog2, neurod1 and ebf3, respectively
(neurog2þMatMO2, n¼66; neurod1þMatMO2, n¼59; ebf3þ
MatMO2, n¼15; Fig. 6G, J and M). These results demonstrate that
maturin can be transcriptionally regulated by all three proneural
transcription factors, is required for the activity of Neurog2,
Neurod1 and Ebf3 in vivo and therefore most likely functions
downstream of these proneural pathway transcription factors
during primary neurogenesis.
Maturin and Pak3 are both required for, and synergize to promote
neural differentiation
The maturin expression pattern, loss-of-function and overexpres-
sion phenotypes indicate Maturin regulates the differentiation of the
primary neurons. The p21-activated kinase 3 (Pak3) regulates the
cell cycle exit and differentiation of primary neurons (Souopgui
et al., 2002). Pak3 is expressed in differentiating neural cells, and like
Maturin, is required downstream of the proneural transcription
factors. Similar to Maturin knockdown, Pak3 knockdown (with
Pak3MO) also inhibits primary neurogenesis and increases cell
proliferation resulting in neural plate expansion (compare Fig. 7A
and B; MatMO2, 100%, n¼290 and Pak3MO, 81%, n¼84). Misexpres-
sion of Pak3 by cRNA injection alters neither tubb2b expression nor
embryonic development (Souopgui et al., 2002). However, when
localized to the cell membrane by artiﬁcial myristoylation, myrPak3
is made constitutively active and at very low doses (5 pg) induces
additional tubb2b expression in the neural plate in a manner similar
to maturin misexpression (compare Fig. 7C and D; maturin, 62%,
n¼149 and myrPak3, 74%, n¼38 and see Hing et al. (1999) and
Souopgui et al. (2002)).
To determine if Maturin function was required before, after, or
with Pak3, we blocked the function of endogenous Maturin or
Pak3 with MatMO2 or Pak3MO, and asked if primary neurogenesis
could be rescued by coinjection with myrPak3 and maturin,
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respectively. Control morpholino did not block the ability of either
myrPak3 or Maturin to induce tubb2b expression (Fig. 7E and F;
CoMOþmyrPak3, 82%, n¼38 and CoMOþmaturin, 62%, n¼40).
Interestingly, Maturin loss-of-function could not be rescued by
constitutively active myrPak3 (Fig. 7G; 0%, n¼20). Similarly,
Maturin could not signiﬁcantly rescue Pak3 loss-of-function
(Fig. 7H; 15%, n¼27). Together, these results demonstrate that
both Maturin and Pak3 are required for primary neurogenesis. To
determine if they might function synergistically, we coinjected
sub-maximal amounts of maturin and myrPak3 cRNAs. Reducing
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Fig. 6. Maturin transcription is induced by, and Maturin function is required for the activity of, the proneural transcription factors. (A–D′) Anterior (A-D) and lateral (A′–D′)
views of maturin expression in embryos misexpressing YFP-only (A, A′), neurog2 (B, B′), neurod1 (C, C′), and ebf3 (D, D′), respectively. Arrows show areas normally lacking
maturin (A, A′), express ectopic maturin when proneural transcription factors are misexpressed (B–D′). (E–M) One blastomere of 2-cell staged embryos were injected with
the indicated proneural transcription factor alone (E, H and K), with control (F, I and L) or Maturin (G, J and M) morpholinos. The effects on tubb2b expression were detected
by whole mount in situ hybridization at stage 15. Right side (viewer's perspective) is the injected side. Scale bar, 400 μm.
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the amount of maturin (400–150 pg) or myrPak3 (5–3 pg) cRNA,
lowered the percent of embryos with an increase in tubb2b
expression from 62% to 12% and from 74% to 26%, respectively
(Fig. 7L). Interestingly, when coexpressed at sub-maximal levels,
Maturin and myrPak3 induced tubb2b expression synergistically
(Fig. 7L). To test this idea further, we injected maturin with non-
myristoylated pak3 cRNA (pak3). In contrast to constitutively active
myrPak3 (74% at 5 pg), concentrations as high as 150 pg of pak3
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Fig. 7. Maturin and Pak3 synergy. (A–K) Embryos were injected unilaterally into one blastomere at the 2-cell stage with the indicated morpholino(s) and/or cRNA(s). At stage
15 in situ hybridization was used to determine the effect on tubb2b expression. (L, M) Graphs illustrate the percent of embryos with additional tubb2b-positive cells in the
lateral stripe, when injected with sub-maximal amounts of maturin, myrPak3, pak3 or the indicated combination of cRNAs. Scale bars, 400 μm. Injected side in all embryos is
right side (viewer's perspective).
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only weakly (14%) induced tubb2b expression (Fig. 7I and M).
Surprisingly, Maturin even functioned synergistically with non-
myristoylated Pak3 (Fig. 7I–K and M). Together, these results
indicate that functional Maturin and Pak3 are both required for
primary neurogenesis. Furthermore, Maturin can function syner-
gistically not only with constitutively active myrPak3, but also
non-myristoylated Pak3 to activate neural differentiation.
Discussion
We report the identiﬁcation of Maturin, a novel protein
required for differentiation during primary neurogenesis. Our
conclusions are supported by the observations that: (1) maturin
transcripts are enriched in the neural plate at the time of primary
neurogenesis and in other neural progenitors as they differentiate;
(2) Maturin knockdown inhibits, while overexpression induces
neuronal differentiation in the neural plate; (3)maturin expression
is induced by the proneural transcription factors Neurog2, Neu-
rod1 and Ebf3; (4) Maturin is required for the proneural transcrip-
tion factors to induce neurogenesis; (5) Maturin and Pak3 are both
required for primary neurogenesis; and (6) Maturin functions
synergistically with Pak3 to promote neural differentiation.
Evolutionary conservation of Maturin
A striking feature of Maturin is its high degree of sequence
conservation, particularly the 29 residue Maturin Motif which is
invariant among vertebrates tested (Fig. 1). Due to its perfect
sequence conservation, it is logical to assume that the Maturin
Motif is critical for the protein's function. Structure–function
analysis of the Maturin Motif (and other conserved regions) will
help deﬁne the importance of these regions during primary
neurogenesis and for Pak3 synergy.
Primary neurogenesis in X. laevis has proven to be an invaluable
tool for discovering conserved genes and genetic interactions
required for neurogenesis (Henningfeld et al., 2007). In frog, maturin
has a dynamic, yet consistent, developmental expression pattern –
low in proliferating neural progenitors, high during differentiation,
then reduced again following differentiation (Figs. 1 and 2). In the
embryonic zebraﬁsh and mouse nervous system, a remarkably
similar expression pattern is also observed (Fig. 2 and R.I.
Martinez-De Luna andM.E. Zuber, unpublished results). Conservation
of both the primary amino acid sequence and expression patterns of
zebraﬁsh, frog and mouse maturins does not of course demonstrate
an identical function for Maturin in all three species. However, it
does strongly suggests that Maturin may have an important role, not
only in Xenopus primary neurogenesis, but also during neural
differentiation in other vertebrate species.
The nature of Maturin/Pak3 synergy
Maturin and Pak3 share many similarities. Both are required for
primary neurogenesis. Morpholino knockdown of either Maturin
or Pak3 inhibits neural differentiation, increases cell proliferation
and results in neural plate expansion. Neurog2, Neurod1 and Ebf3
can all induce both maturin and pak3 transcription (this work and
Souopgui et al. (2002)). Both Maturin and Pak3 loss-of-function
also block the ability of the proneural transcription factors
Neurog2, Neurod1 and Ebf3 to induce ectopic neural differentia-
tion. Both Maturin and Pak3 are sufﬁcient for primary neurogen-
esis. Maturin and Pak3 (myrPak3) gain-of-function by cRNA
injection promotes neural differentiation (this work and
Souopgui et al. (2002)). Despite the fact they can both induce
primary neurogenesis, Maturin and Pak3 appear to be interde-
pendent. MyrPak3 and Maturin cannot rescue the Maturin and
Pak3 knockdown phenotypes, respectively. Furthermore, Maturin
functions synergistically not only with constitutively active myr-
Pak3, but also Pak3. Together, these results are most consistent
with a role for Maturin in the proneural pathway, downstream of
the proneural transcription factors where both Maturin and Pak3
functions are required during primary neurogenesis (Fig. 8).
Pak3 kinase activity is required for myrPak3 to induce differ-
entiation, and 14 of the 131 Maturin residues are serines or
threonines (Fig. 1 and Souopgui et al. (2002)). Although only eight
of these residues are conserved and none lie in a Pak consensus
phosphorylation site, it will be important to determine if a
physical association of these proteins is required for synergy,
Pak3 kinase activity, and/or possible Maturin phosphorylation
(Fig. 1 and Gururaj et al. (2005), King et al. (2001) and
Rennefahrt et al. (2007)).
Known activators of Pak protein kinase activity are Rac1 and
Cdc42 GTPases, and Paks are recruited to the plasma membrane
via their interactions with adaptor proteins (Arias-Romero and
Chernoff, 2008; Bokoch, 2003; Kreis and Barnier, 2009). For
example, human Pak1 is recruited to active tyrosine kinase
receptors in the membrane by the SH3 domain of the adaptor
protein Nck and its membrane localization results in kinase
activation (Galisteo et al., 1996; Lu and Mayer, 1999). The increase
in neural differentiation observed after misexpression of Maturin
with non-myristoylated Pak3 may suggest a role for Maturin in
recruiting or targeting Pak3 to the plasma membrane. However,
Maturin may be part of a protein complex that recruits Pak3 to the
membrane for kinase activation and subsequent activation of
downstream differentiation signals. In this model, a direct inter-
action of Maturin and Pak3 would be predicted (Fig. 8A)
It is important to note, that we cannot discount alternative
hypotheses. Unlike pak3 (and the proneural transcription factors),
maturin expression is not only detected in the differentiating
primary neurons, but also throughout the neural plate before
and during primary neurogenesis (Fig. 1 and (Chalmers et al.,
2002; Lee et al., 1995; Ma et al., 1996; Pozzoli et al., 2001;
Souopgui et al., 2002)). Maturin and Pak3 may function in
independent pathways, both of which are required for primary
neurogenesis (Fig. 8B). In addition, Maturin may also have a role in
regulating neural progenitor proliferation prior to neural differ-
entiation. This possibility is consistent with our observation that
Maturin knockdown results in an expansion of the sox2 and rax
Maturin•Pak3
Neurog2
Neurod1
Ebf3
Primary Neurogenesis
(tubb2b)
Maturin      Pak3
Primary Neurogenesis
(tubb2b)
Neurog2
Neurod1
Ebf3
Fig. 8. Proposed gene networks illustrating the most likely position of Maturin in
the proneural pathway. Maturin and Pak3 function together downstream of the
proneural transcription factors to promote differentiation of the primary neurons.
Our results are consistent with models in which Maturin and Pak3 form a complex
(A), or function independently (B). In both models, Maturin and Pak3 are both
required for normal primary neurogenesis.
R.I. Martinez-De Luna et al. / Developmental Biology 384 (2013) 26–4038
expression domains in the anterior neural plate, where neural
differentiation has not yet started (Fig. 3K and L).
Primary neurogenesis in the Xenopus neural plate has served as
an important model for identifying the molecules and mechan-
isms responsible for neural differentiation in other tissues and
species. The expression of Maturin in differentiating retina, brain
and spinal cord neurons in ﬁsh, frog, and mice, implies a role not
only in primary neurogenesis, but also in the differentiation of
cells in other regions of the nervous system. Maturin is an
evolutionarily conserved, novel protein with no identiﬁable func-
tional domains. Understanding the mechanism(s) by which
Maturin regulates neurogenesis will identify it as a new molecular
component of know signaling systems, or as part of a new,
previously unidentiﬁed signaling system required for differentia-
tion of the primary neurons.
Acknowledgments
We would like thank the following for providing plasmids:
Monica Vetter (pCS2þ .Ebf3), Sally Moody (pBSSKþ .Sox2, pBSKSþ
.tubb2b, pCS2þ .neurog2, and pCS2þMT.NeuroD), Tomas Pieler
(pCS2þ .myrPak3 and pBK-CMV.Pak3). We also thank Heather
Nihart, Matthew Mellini, Jeffrey Amack and Andrea Viczian for
technical assistance, Nancy Papalopulu for the detailed ﬁsh gelatin
embedding and sectioning protocol, Jeffrey Amack and Katharine
Lewis for providing wild type and elav3l:GFP transgenic zebraﬁsh
embryos, and Andrea Viczian and Francesca Pignoni for sugges-
tions on the manuscript. Research reported in this publication was
supported by the National Eye Institute of the National Institutes
of Health under award numbers R01EY017964 and R01EY015748
(MEZ), a Research to Prevent Blindness unrestricted grant to the
Upstate Medical University Department of Ophthalmology, and the
Lions Club of Central New York.
Appendix A. Supporting information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.ydbio.2013.09.028.
References
Agathocleous, M., Harris, W.A., 2009. From progenitors to differentiated cells in the
vertebrate retina. Annual Review of Cell and Developmental Biology 25, 45–69.
Andreazzoli, M., Gestri, G., Cremisi, F., Casarosa, S., Dawid, I.B., Barsacchi, G., 2003.
Xrx1 controls proliferation and neurogenesis in Xenopus anterior neural plate.
Development 130, 5143–5154.
Arias-Romero, L.E., Chernoff, J., 2008. A tale of two Paks. Biology of the Cell 100,
97–108.
Bokoch, G.M., 2003. Biology of the p21-activated kinases. Annual Review of
Biochemistry 72, 743–781.
Chalmers, A.D., Strauss, B., Papalopulu, N., 2003. Oriented cell divisions asymme-
trically segregate aPKC and generate cell fate diversity in the early Xenopus
embryo. Development 130, 2657–2668.
Chalmers, A.D., Welchman, D., Papalopulu, N., 2002. Intrinsic differences between
the superﬁcial and deep layers of the Xenopus ectoderm control primary
neuronal differentiation. Developmental Cell 2, 171–182.
Chitnis, A., Henrique, D., Lewis, J., Ish-Horowicz, D., Kintner, C., 1995. Primary
neurogenesis in Xenopus embryos regulated by a homologue of the Drosophila
neurogenic gene Delta. Nature 375, 761–766.
Dehay, C., Kennedy, H., 2007. Cell-cycle control and cortical development. Nature
Reviews Neuroscience 8, 438–450.
Donovan, S.L., Dyer, M.A., 2005. Regulation of proliferation during central nervous
system development. Seminars in Cell and Developmental Biology 16, 407–421.
Dyer, M.A., Cepko, C.L., 2001. Regulating proliferation during retinal development.
Nature Reviews Neuroscience 2, 333–342.
Galisteo, M.L., Chernoff, J., Su, Y.C., Skolnik, E.Y., Schlessinger, J., 1996. The adaptor
protein Nck links receptor tyrosine kinases with the serine-threonine kinase
Pak1. Journal of Biological Chemistry 271, 20997–21000.
Good, P.J., Richter, K., Dawid, I.B., 1989. The sequence of a nervous system-speciﬁc,
class II beta-tubulin gene from Xenopus laevis. Nucleic Acids Research 17, 8000.
Guillemot, F., 2007. Cell fate speciﬁcation in the mammalian telencephalon.
Progress in Neurobiology 83, 37–52.
Gururaj, A.E., Rayala, S.K., Kumar, R., 2005. p21-activated kinase signaling in breast
cancer. Breast Cancer Research 7, 5–12.
Hartenstein, V., 1989. Early neurogenesis in Xenopus: the spatio-temporal pattern
of proliferation and cell lineages in the embryonic spinal cord. Neuron 3,
399–411.
Hemmati-Brivanlou, A., Melton, D.A., 1994. Inhibition of activin receptor signaling
promotes neuralization in Xenopus. Cell 77, 273–281.
Henningfeld, K.A., Locker, M., Perron, M., 2007. Xenopus primary neurogenesis and
retinogenesis. Functional Development and Embryology 1, 26–36.
Hensey, C., Gautier, J., 1998. Programmed cell death during Xenopus development:
a spatio-temporal analysis. Developmental Biology 203, 36–48.
Hindley, C., Philpott, A., 2012. Co-ordination of cell cycle and differentiation in the
developing nervous system. Biochemical Journal 444, 375–382.
Hing, H., Xiao, J., Harden, N., Lim, L., Zipursky, S.L., 1999. Pak functions downstream
of Dock to regulate photoreceptor axon guidance in Drosophila. Cell 97,
853–863.
Holt, C.E., Bertsch, T.W., Ellis, H.M., Harris, W.A., 1988. Cellular determination in the
Xenopus retina is independent of lineage and birth date. Neuron 1, 15–26.
Kimmel, C.B., Ballard, W.W., Kimmel, S.R., Ullmann, B., Schilling, T.F., 1995. Stages of
embryonic development of the zebraﬁsh. Developmental Dynamics 203,
253–310.
King, A.J., Wireman, R.S., Hamilton, M., Marshall, M.S., 2001. Phosphorylation site
speciﬁcity of the Pak-mediated regulation of Raf-1 and cooperativity with Src.
FEBS Letters 497, 6–14.
Klisch, T.J., Souopgui, J., Juergens, K., Rust, B., Pieler, T., Henningfeld, K.A., 2006.
Mxi1 is essential for neurogenesis in Xenopus and acts by bridging the pan-
neural and proneural genes. Developmental Biology 292, 470–485.
Kreis, P., Barnier, J.V., 2009. PAK signalling in neuronal physiology. Cellular
Signalling 21, 384–393.
Lee, J.E., Hollenberg, S.M., Snider, L., Turner, D.L., Lipnick, N., Weintraub, H., 1995.
Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix–loop–
helix protein. Science 268, 836–844.
Lu, W., Mayer, B.J., 1999. Mechanism of activation of Pak1 kinase by membrane
localization. Oncogene 18, 797–806.
Ma, Q., Kintner, C., Anderson, D.J., 1996. Identiﬁcation of neurogenin, a vertebrate
neuronal determination gene. Cell 87, 43–52.
Marchler-Bauer, A., Lu, S., Anderson, J.B., Chitsaz, F., Derbyshire, M.K., DeWeese-
Scott, C., Fong, J.H., Geer, L.Y., Geer, R.C., Gonzales, N.R., Gwadz, M., Hurwitz, D.I.,
Jackson, J.D., Ke, Z., Lanczycki, C.J., Lu, F., Marchler, G.H., Mullokandov, M.,
Omelchenko, M.V., Robertson, C.L., Song, J.S., Thanki, N., Yamashita, R.A., Zhang,
D., Zhang, N., Zheng, C., Bryant, S.H., 2011. CDD: a Conserved Domain Database
for the functional annotation of proteins. Nucleic Acids Research 39,
D225–D229.
Mathers, P.H., Grinberg, A., Mahon, K.A., Jamrich, M., 1997. The Rx homeobox gene
is essential for vertebrate eye development. Nature 387, 603–607.
Mizuseki, K., Kishi, M., Matsui, M., Nakanishi, S., Sasai, Y., 1998. Xenopus Zic-
related-1 and Sox-2, two factors induced by chordin, have distinct activities in
the initiation of neural induction. Development 125, 579–587.
Nieuwkoop, P.D., Faber, J., 1994. Normal Table of Xenopus Laevis (Daudin): A Systematical
& Chronological Survey of the Development from the Fertilized Egg till the End of.
the Fertilized Egg till the End of Metamorp. Garland Science, New York.
Oschwald, R., Richter, K., Grunz, H., 1991. Localization of a nervous system-speciﬁc
class II beta-tubulin gene in Xenopus laevis embryos by whole-mount in situ
hybridization. International Journal of Developmental Biology 35, 399–405.
Pagni, M., Ioannidis, V., Cerutti, L., Zahn-Zabal, M., Jongeneel, C.V., Hau, J., Martin, O.,
Kuznetsov, D., Falquet, L., 2007. MyHits: improvements to an interactive
resource for analyzing protein sequences. Nucleic Acids Research 35,
W433–W437.
Park, H.C., Kim, C.H., Bae, Y.K., Yeo, S.Y., Kim, S.H., Hong, S.K., Shin, J., Yoo, K.W., Hibi,
M., Hirano, T., Miki, N., Chitnis, A.B., Huh, T.L., 2000. Analysis of upstream
elements in the HuC promoter leads to the establishment of transgenic
zebraﬁsh with ﬂuorescent neurons. Developmental Biology 227, 279–293.
Petersen, T.N., Brunak, S., von Heijne, G., Nielsen, H., 2011. SignalP 4.0: discriminating
signal peptides from transmembrane regions. Nature Methods 8 (10), 785–786.
Pozzoli, O., Bosetti, A., Croci, L., Consalez, G.G., Vetter, M.L., 2001. Xebf3 is a
regulator of neuronal differentiation during primary neurogenesis in Xenopus.
Developmental Biology 233, 495–512.
Quevillon, E., Silventoinen, V., Pillai, S., Harte, N., Mulder, N., Apweiler, R., Lopez, R.,
2005. InterProScan: protein domains identiﬁer. Nucleic Acids Research 33,
W116–W120.
Regad, T., Roth, M., Bredenkamp, N., Illing, N., Papalopulu, N., 2007. The neural
progenitor-specifying activity of FoxG1 is antagonistically regulated by CKI and
FGF. Nature Cell Biology 9, 531–540.
Rennefahrt, U.E., Deacon, S.W., Parker, S.A., Devarajan, K., Beeser, A., Chernoff, J.,
Knapp, S., Turk, B.E., Peterson, J.R., 2007. Speciﬁcity proﬁling of Pak kinases
allows identiﬁcation of novel phosphorylation sites. Journal of Biological
Chemistry 282, 15667–15678.
Saka, Y., Smith, J.C., 2001. Spatial and temporal patterns of cell division during early
Xenopus embryogenesis. Developmental Biology 229, 307–318.
Salomoni, P., Calegari, F., 2010. Cell cycle control of mammalian neural stem cells:
putting a speed limit on G1. Trends in Cell Biology 20, 233–243.
Sigrist, C.J., Cerutti, L., de Castro, E., Langendijk-Genevaux, P.S., Bulliard, V., Bairoch,
A., Hulo, N., 2010. PROSITE, a protein domain database for functional char-
acterization and annotation. Nucleic Acids Research 38, D161–D166.
R.I. Martinez-De Luna et al. / Developmental Biology 384 (2013) 26–40 39
Sive, H.L., Grainger, R.M., Harland, R.M., 2000. Early development of Xenopus laevis:
a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor,
N.Y..
Souopgui, J., Solter, M., Pieler, T., 2002. XPak3 promotes cell cycle withdrawal
during primary neurogenesis in Xenopus laevis. EMBO Journal 21, 6429–6439.
Viczian, A.S., Bang, A.G., Harris, W.A., Zuber, M.E., 2006. Expression of Xenopus laevis
Lhx2 during eye development and evidence for divergent expression among
vertebrates. Developmental Dynamics 235, 1133–1141.
Viczian, A.S., Solessio, E.C., Lyou, Y., Zuber, M.E., 2009. Generation of functional eyes
from pluripotent cells. PLOS Biology 7, e1000174.
Viczian, A.S., Vignali, R., Zuber, M.E., Barsacchi, G., Harris, W.A., 2003. XOtx5b and
XOtx2 regulate photoreceptor and bipolar fates in the Xenopus retina. Devel-
opment 130, 1281–1294.
Zuber, M.E., Gestri, G., Viczian, A.S., Barsacchi, G., Harris, W.A., 2003. Speciﬁcation of
the vertebrate eye by a network of eye ﬁeld transcription factors. Development
130, 5155–5167.
Zuber, M.E., Perron, M., Philpott, A., Bang, A., Harris, W.A., 1999. Giant eyes in
Xenopus laevis by overexpression of XOptx2. Cell 98, 341–352.
R.I. Martinez-De Luna et al. / Developmental Biology 384 (2013) 26–4040
